Ryan Atkins

Strainz, Inc. operates as a cannabis brand management firm. It offers Ratio Vape cartridges and Ratio Tinctures. The company was founded in 2014 and is headquartered in Las Vegas, NV.

Subway Developments 2000, Inc. operates subway restaurants. The private company is based in Coquitlam, Canada.

Founded in 1997, Joseph Gunnar & Co. LLC is a full-service broker/dealer headquartered in New York City. The firm is a subsidiary of Joseph Gunnar Holding Co. LLC They provide financial advisory, brokerage and trading for investors in connection with listed equities, corporate and municipal bonds, preferred stock, mutual funds, IRA, pension plans and NASDAQ NMS securities.

Part of ARC Group Ltd. (China), Luminous Capital, Inc. is a private equity firm with a focus on the regulated US cannabis industry and other high-growth, emerging-market industries. The company is based in New York, NY. The company has offices in , , and and takes an active role in all its investments by leveraging its existing relationships and experience. Luminous Capital offers a range of services to investors and operators around the world, utilizing its reach, access to synergistic capital partners, and operational expertise. The company was founded in 2019 by Joshua Mann and John Darwin. Luminous Capital was acquired by ARC Group Ltd. (China) on February 14, 2023.

Bertram Capital Finance, Inc. engages in the provision of banking and financial services. The company was founded by Jeffery Allan Mascio in 2015 and is headquartered in Denver, CO.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin.